[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-id-113":3,"doc-seo-332687-113":53,"doc-detail-332687-id":127},{"code":4,"msg":5,"data":6},0,"success",[7,13,17,21,25,29,33,37,41,45,49],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},55,"Document","Agama & Spiritualitas",60,"religion-spirituality",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":11,"slug":16},48,"Cerita & Novel","story-novel",{"id":18,"doc_module":4,"doc_module_name":9,"category_name":19,"show_sort_weight":11,"slug":20},56,"Gaya Hidup","lifestyle",{"id":22,"doc_module":4,"doc_module_name":9,"category_name":23,"show_sort_weight":11,"slug":24},51,"Komik","comic",{"id":26,"doc_module":4,"doc_module_name":9,"category_name":27,"show_sort_weight":11,"slug":28},53,"Layanan Kesehatan","healthcare",{"id":30,"doc_module":4,"doc_module_name":9,"category_name":31,"show_sort_weight":11,"slug":32},54,"Penelitian & Laporan","research-report",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":11,"slug":36},49,"Sastra","literature",{"id":38,"doc_module":4,"doc_module_name":9,"category_name":39,"show_sort_weight":11,"slug":40},52,"Teknologi","technology",{"id":42,"doc_module":4,"doc_module_name":9,"category_name":43,"show_sort_weight":11,"slug":44},50,"Ujian","exam",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":47,"show_sort_weight":11,"slug":48},57,"Umum","general",{"id":50,"doc_module":4,"doc_module_name":9,"category_name":51,"show_sort_weight":4,"slug":52},181,"Formulir","formulir",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":120,"head_meta":122,"extra_data":124,"updated_unix":126},113,"id","correspondence-document-tablet-formulation-of-2-3-chloromethylbenzoyloxybenzoic-acid-by-linear-and-quadratic-models","DOKUMEN KORESPODENSI - Tablet Formulation of 2-((3-(Chloromethyl)benzoyl)oxy)benzoic Acid by Linear and Quadratic Models","","Dokumen korespondensi terkait pengajuan naskah jurnal ACS Omega dengan judul “Tablet formulation of 2-((3-(Chloromethyl)benzoyl)oxy)benzoic acid by linear and quadratic models”. Mencantumkan identitas jurnal, volume/issue, tahun, DOI, penulis pertama, dan penulis korespondensi Wuryanto Hadinugroho. Terdapat ringkasan tahapan proses mulai submission, permintaan revisi pertama–ketiga, penyerahan revisi beserta respons reviewer, hingga status diterima dan proses perjanjian publikasi serta proof. Juga memuat detail email korespondensi serta klausul kerahasiaan peer review.",{"@graph":63,"@context":119},[64,81,102],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,72,75,78],{"item":68,"name":69,"@type":70,"position":71},"https://docshare.wps.com","Home","ListItem",1,{"item":73,"name":9,"@type":70,"position":74},"https://docshare.wps.com/id/document/",2,{"item":76,"name":31,"@type":70,"position":77},"https://docshare.wps.com/id/document/penelitian-laporan/",3,{"item":79,"name":59,"@type":70,"position":80},"https://docshare.wps.com/id/document/correspondence-document-tablet-formulation-of-2-3-chloromethylbenzoyloxybenzoic-acid-by-linear-and-quadratic-models/332687/",4,{"url":79,"name":59,"@type":82,"image":83,"author":88,"headline":59,"publisher":91,"fileFormat":94,"inLanguage":57,"description":61,"dateModified":95,"datePublished":96,"encodingFormat":94,"isAccessibleForFree":97,"interactionStatistic":98},"DigitalDocument",{"url":84,"@type":85,"width":86,"height":87},"https://docshare.wps.com/thumbnails/correspondence-document-tablet-formulation-of-2-3-chloromethylbenzoyloxybenzoic-acid-by-linear-and-quadratic-models/332687.png","ImageObject",300,407,{"name":89,"@type":90},"Mary Man","Person",{"url":68,"name":92,"@type":93},"DocShare","Organization","application/pdf","2026-10-04","2026-09-21",true,{"@type":99,"interactionType":100,"userInteractionCount":77},"InteractionCounter",{"@type":101},"ViewAction",{"@type":103,"mainEntity":104},"FAQPage",[105,111,115],{"name":106,"@type":107,"acceptedAnswer":108},"Apa yang dicantumkan dalam dokumen korespondensi ini terkait naskah ACS Omega?","Question",{"text":109,"@type":110},"Dokumen mencantumkan identitas jurnal, judul naskah, DOI, informasi penulis (termasuk penulis korespondensi Wuryanto Hadinugroho), status manuskrip, serta kronologi tahapan submission dan revisi hingga publikasi.","Answer",{"name":112,"@type":107,"acceptedAnswer":113},"Bagaimana urutan tahapan revisi pada proses review yang tercatat?",{"text":114,"@type":110},"Tercatat submission awal, permintaan revisi pertama, penyerahan revisi pertama dan respons reviewer, kemudian permintaan revisi kedua dan penyerahan revisi kedua beserta respons, lalu permintaan revisi ketiga, penyerahan revisi ketiga, hingga diterima untuk publikasi serta proses perjanjian dan proof.",{"name":116,"@type":107,"acceptedAnswer":117},"Apa saja kewajiban yang disebutkan terkait Journal Publishing Agreement setelah naskah diterima?",{"text":118,"@type":110},"Setelah acceptance, penulis korespondensi diminta menandatangani dan menyerahkan Journal Publishing Agreement melalui Journal Publishing Agreement Wizard untuk memilih lisensi yang sesuai, dengan pengaturan hak penggunaan manuskrip.","https://schema.org",{"og:url":79,"og:type":121,"og:title":59,"og:site_name":92,"og:description":61},"article",{"robots":123,"canonical":79},"index,follow",{"doc_id":125,"site_id":56},332687,1790462676,{"code":4,"msg":5,"data":128},{"doc_id":125,"user_id":129,"nickname":89,"user_avatar":130,"doc_module":4,"category_id":30,"category_name":31,"doc_title":59,"doc_description":61,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":77,"is_deleted":4,"is_public":71,"is_downloadable":71,"audit_status":71,"page_count":136,"language":137,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":138,"faqs":139,"seo_title":140,"seo_description":61,"update_tm":141,"read_time":142},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOKUMEN KORESPODENSI  \nNama Jurnal : ACS Omega  \nJudul : Tablet Formulation of 2‑((3-(Chloromethyl)benzoyl)oxy)benzoic Acid by Linear  \nand Quadratic Models  \nPublisher : ACS Publications  \nVolume/Issue : 7(38)  \nTahun : 2022  \nDOI : [https://doi.org/10.1021/acsomega.2c03147](https://doi.org/10.1021/acsomega.2c03147)  \n[Index](Index : SJR)[ : SJR](Index : SJR)([2022](2022)) 0.694  \nPenulis Pertama : Wuryanto Hadinugroho  \nPenulis Korespodensi : Wuryanto Hadinugroho Tahapan & Lampiran :  \n\n| No. | Tahapan | Waktu |\n| --- | --- | --- |\n| 1. | Submission to ACS Omega\u003Cbr>Email success submitted\u003Cbr>Manuscript draft | 20-05-2022 |\n| 2. | First revision request\u003Cbr>Email first revision request from reviewer\u003Cbr>Email first revision request from editorial | 16-06-2022 |\n| 3. | Submission of first revision to ACS Omega\u003Cbr>Email success submitted first revision\u003Cbr>Manuscript draft first revision\u003Cbr>Response to reviewers comments (first revision) | 06-07-2022 |\n| 4. | Second revision request\u003Cbr>Email second revision request from reviewer | 02-08-2022 |\n| 5. | Submission of second revision to ACS Omega\u003Cbr>Email success submitted second revision\u003Cbr>Manuscript draft of second revision\u003Cbr>Response to reviewers comments (second revision) | 03-08-2022 |\n| 6. | Third revision request\u003Cbr>Email third revision request from editorial |  |\n| 7. | Submission of third revision to ACS Omega\u003Cbr>Email success submitted third revision\u003Cbr>Form Author Charge\u003Cbr>Manuscript draft of third revision\u003Cbr>Response to reviewers comments (third revision) | 15-08-2022 |\n| 8. | Accepted for publication\u003Cbr>Email accepted for publication | 17-08-2022 |\n| 9. | Journal publishing agreement request\u003Cbr>Email Journal publishing agreement request | 17-08-2022 |\n| 10. | Journal publishing agreement received\u003Cbr>Email journal publishing agreement received | 18-08-2022 |\n| 11. | Review proof request\u003Cbr>Email review proof request | 25-08-2022 |\n| 12. | Corrections proof received\u003Cbr>Email corrections proof received\u003Cbr>Paper proof accepted | 30-08-2022 |\n| 13. | Paper publish\u003Cbr>Email paper publish | 13-09-2022 |\n\nHadinugroho, Wuryanto ao-2022-031476-Manuscript Submission to ACS Omega 20-May- 2022  \nDari: ACS Omega ([onbehalfof@manuscriptcentral.com](onbehalfof@manuscriptcentral.com))  \nKepada: [wuryanto.hadinugroho@ymail.com](wuryanto.hadinugroho@ymail.com)  \nCc: [wuryanto.hadinugroho@ymail.com](wuryanto.hadinugroho@ymail.com); [kuncoro@ukwms.ac.id](kuncoro@ukwms.ac.id); [yudy.tjahjono@ukwms.ac.id](yudy.tjahjono@ukwms.ac.id); [caroline@ukwms.ac.id](caroline@ukwms.ac.id); [senny_93@ukwms.ac.id](senny_93@ukwms.ac.id); [marbel@ukwms.ac.id](marbel@ukwms.ac.id)  \nTanggal: Jumat, 20 Mei 2022 pukul 22.41 GMT+7  \n20-May-2022  \nJournal: ACS Omega  \nManuscript ID: ao-2022-031476  \nTitle: \"Tablet formulation of 2-((3-(chloromethyl)benzoyl)oxy)benzoic acid by linear and quadratic models\"  \nAuthors: Hadinugroho, Wuryanto; Foe, Kuncoro; Tjahjono, Yudy; Caroline, Caroline; Esar, Senny; Jessica, Maria  \nManuscript Status: Submitted  \nDear Dr. Hadinugroho:  \nYour manuscript has been successfully submitted to ACS Omega, a multidisciplinary, open access journal for the publication of original and scientifically valid research. The journal offers expedited editorial decision-making and immediate open availability. Authors can rapidly publish their important research results and broadly distribute them to the global scientific community. Please note that there are publishing charges associated with this journal. Details can be found at [http://acsopenscience.org. Should](http://acsopenscience.org. Should) your manuscript be accepted, you will be required to pay for the Article Publishing Charges prior to publication. Authors may qualify for discounts. Article Publishing Charges are waived for invited Editorials and Perspectives.  \nPlease reference the above manuscript ID in all future correspondence. If there are any changes in your contact information, please log in to ACS Paragon Plus with your ACS ID ","cbCaiaNecBSgkubs","https://ap.wps.com/l/cbCaiaNecBSgkubs","pdf",9509834,170,"Indonesian","# Informasi Jurnal dan Naskah\n## Identitas publikasi (Nama jurnal, volume/issue, tahun, DOI)\n## Penulis dan status manuskrip\n# Tahapan Korespondensi dan Revisi\n## Submission dan permintaan revisi\n## Penyerahan revisi serta respons reviewer\n## Persetujuan publikasi dan proof\n# Isi Email dan Ketentuan\n## Ringkasan pengajuan dan notifikasi\n## Journal Publishing Agreement dan copyright\n## Kerahasiaan peer review","[{\"question\":\"Apa yang dicantumkan dalam dokumen korespondensi ini terkait naskah ACS Omega?\",\"answer\":\"Dokumen mencantumkan identitas jurnal, judul naskah, DOI, informasi penulis (termasuk penulis korespondensi Wuryanto Hadinugroho), status manuskrip, serta kronologi tahapan submission dan revisi hingga publikasi.\"},{\"question\":\"Bagaimana urutan tahapan revisi pada proses review yang tercatat?\",\"answer\":\"Tercatat submission awal, permintaan revisi pertama, penyerahan revisi pertama dan respons reviewer, kemudian permintaan revisi kedua dan penyerahan revisi kedua beserta respons, lalu permintaan revisi ketiga, penyerahan revisi ketiga, hingga diterima untuk publikasi serta proses perjanjian dan proof.\"},{\"question\":\"Apa saja kewajiban yang disebutkan terkait Journal Publishing Agreement setelah naskah diterima?\",\"answer\":\"Setelah acceptance, penulis korespondensi diminta menandatangani dan menyerahkan Journal Publishing Agreement melalui Journal Publishing Agreement Wizard untuk memilih lisensi yang sesuai, dengan pengaturan hak penggunaan manuskrip.\"}]","DOKUMEN KORESPODENSI - Tablet Formulation of 2-((3-(Chloromethyl)benzoyl)oxy)benzoic Acid by Linear and Quadratic Models | PDF",1789999074,262]